Delia A. Deschaine, Member of the Firm, moderates a panel of speakers for "The Hazy Legal Status of Delta-8 THC and Other Chemically Modified Cannabinoids" on-demand webinar, hosted by the Food and Drug Law Institute. This webinar will first delve into the chemistry of these modified cannabinoids, how they are derived, possible safety concerns, and their similarities and differences from Delta-9 THC. Speakers will then discuss the legal status of these relatively new cannabinoids under FDA, USDA, and DEA rules, the evolving nature of state bans, and the potential influence on policy discussions about other cannabis products.
For more information and to register, please visit FDLI.org.